Home / Companies / Aragen Life Sciences

Aragen Life Sciences

CRO (CDMO)Hyderabad, India

Hyderabad-based contract research, development and manufacturing organisation (CRDMO) serving global life sciences innovators across small molecules and biologics. Formerly GVK Biosciences, it operates sites across India and the United States and served 591 customers in FY26.

1StartupFox story
2000Founded
CRO(CDMO)Sector
Aug 2026Latest coverage

Funding

Aragen Life Sciences has raised $100M across 1 disclosed round, most recently a Private equity investment in January 2025.

$100MRaised
Private equity investmentLatest round · January 2025
$1.4BValuation
1Event
Chart appears once 2 more funding rounds are recorded — below that a chart shows less than the table does.
January 2025Private equity investment$100MQuadria Capital ~$1.4 billion

The rest of Aragen Life Sciences's profile is free

Every funding round with its source, verified financials, leadership and the full journey timeline — sign in once and it stays unlocked.

One tap. No newsletter unless you ask for it.

Latest on Aragen Life Sciences

Markets & IPO
Aragen Files for IPO With ₹800 Crore Fresh Issue as FY26 Revenue Hits ₹2,178 Crore
31 AUG 2026 · 5 MIN READ

Also in Other

AgilitasSportswear / AthleisureEthereal MachinesAdvanced Manufacturing / DeeptechJJava SportsSports Equipment / Manufacturing30 SundaysTravel Technology

Frequently Asked

What is Aragen Life Sciences?

Hyderabad-based contract research, development and manufacturing organisation (CRDMO) serving global life sciences innovators across small molecules and biologics. Formerly GVK Biosciences, it operates sites across India and the United States and served 591 customers in FY26.

Who founded Aragen Life Sciences?

Aragen Life Sciences is associated with Manni Kantipudi.

How much funding has Aragen Life Sciences raised?

Aragen Life Sciences has raised $100M across 1 disclosed round. The most recent was a $100M Private equity investment in January 2025.

Who are Aragen Life Sciences's investors?

Disclosed investors in Aragen Life Sciences include Quadria Capital.

What is Aragen Life Sciences's valuation?

Aragen Life Sciences was last reported at ~$1.4 billion, at the time of its Private equity investment in January 2025.

What is the latest news on Aragen Life Sciences?

The most recent StartupFox coverage is “Aragen Files for IPO With ₹800 Crore Fresh Issue as FY26 Revenue Hits ₹2,178 Crore” (31 August 2026). All stories are listed on this page.